Creatine kinase, a magnetic resonance-detectable marker gene for quantification of liver-directed gene transfer

Human Gene Therapy

Volumn 16, Issue 12, 2005, Pages 1429-1438

  Li, Zijun ^a   Qiao, Hui ^a   Lebherz, Corinna ^a   Choi, Seok Rye ^a   Zhou, Xiangyang ^a   Gao, Guanping ^a   Kung, Hank F ^a   Rader, Daniel J ^a   Wilson, James M ^a   Glickson, Jerry D ^a   Zhou, Rong ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CREATINE KINASE; CREATINE PHOSPHATE; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FAMILIAL HYPERCHOLESTEROLEMIA; FEASIBILITY STUDY; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETIC TRANSDUCTION; IN VITRO STUDY; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; LIVER; MALE; MARKER GENE; MOUSE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RECEPTOR GENE; REPORTER GENE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS PARTICLE; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; CREATINE KINASE; FEASIBILITY STUDIES; GENE EXPRESSION; GENES, REPORTER; GENETIC MARKERS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MICE; RECEPTORS, LDL; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; ANIMALIA;

EID: 29244442729     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.1429     Document Type: Article

References (52)

1. 18F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET. J. Nucl. Med. 42, 1682-1690.
2. ARNOLD, K.S., INNERARITY, I., PITAS, R.E., and MAHLEY, R.W. (1992). Lipoprotein-Receptor Interactions. (Oxford University Press, Oxford).
3. 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene. Proc. Natl. Acad. Sci. U.S.A. 98, 5205-5210.
4. 31P NMR magnetization transfer study. J. Biol. Chem. 260, 3512-3517.
5. 31P NMR surface coil studies in brain, heart, and skeletal muscle of the living rat. Biochemistry 26, 6083-6090.
6. BORNHOP, D.J., CONTAG, C.H., LICHA, K., and MURPHY, C.J. (2001). Advance in contrast agents, reporters, and detection. J. Biomed. Optics 6, 106-110.
7. BOTTOMLEY, P.A., OUWERKERK, R., LEE, R.F., and WEISS, R.G. (2002). Four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo. Magn. Reson. Med. 47, 850-863.
8. BOWEN, C.V., ZHANG, X., SAAB, G., GAREAU, P.J., and RUTT, B.K. (2002). Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn. Reson. Med. 48, 52-61.
9. BROSNAN, M.J., CHEN, L., VAN DYKE, T.A., and KORETSKY, A.P. (1990). Free ADP levels in transgenic mouse liver expressing creatine kinase: Effects of enzyme activity, phosphagen type, and substrate concentration. J. Biol. Chem. 265, 20849-20855.
10. BROSNAN, M.J., RAMAN, S.P., CHEN, L., and KORETSKY, A.P. (1993). Altering creatine kinase isoenzymes in transgenic mouse muscle by overexpression of the B subunit. Am. J. Physiol. 264, C151-C160.
11. CHEN, I.Y., WU, J.C., MIN, J.J., SUNDARESAN, G., LEWIS, X., LIANG, Q., HERSCHMAN, H.R., and GAMBHIR, S.S. (2004). Micro-positron emission tomography imaging of cardiac gene expression in rats using bicistronic adenoviral vector-mediated gene delivery. Circulation 109, 1415-1420.
12. COHEN, B., DAFNI, H., MEIR, G., HARMELIN, A., and NEEMAN, M. (2005). Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 7, 109-117.
13. CONTAG, C.H., SPILMAN, S.D., CONTAG, P.R., OSHIRO, M., EAMES, B., DENNERY, P., STEVENSON, D.K., and BENARON, D.A. (1997). Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem. Photobiol. 66, 523-531.
14. CONTAG, C.H., JENKINS, D., CONTAG, P.R., and NEGRIN, R.S. (2000). Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia (New York) 2, 41-52.
15. CONTAG, P.R., OLOMU, I.N., STEVENSON, D.K., and CONTAG, C.H. (1998). Bioluminescent indicators in living mammals. Nat. Med. 4, 245-247.
16. DAWSON, D.M., and FINE, I.H. (1967). Creatine kinase in human tissues. Arch. Neurol. 16, 175-180.
17. ENAT, R., JEFFERSON, D.M., RUIZ-OPAZO, N., GATMAITAN, Z., LEINWAND, L.A., and REID, L.M. (1984). Hepatocyte proliferation in vitro: Its dependence on the use of serum-free hormonally defined medium and substrata of extracellular matrix. Proc. Natl. Acad. Sci. U.S.A. 81, 1411-1415.
18. GAMBHIR, S.S., BARRIO, J.R., WU, L., IYER, M., NAMAVARI, M., SATYAMURTHY, N., BAUER, E., PARRISH, C., MACLAREN, D.C., BORGHEI, A.R., GREEN, L.A., SHARFSTEIN, S., BERK, A.J., CHERRY, S.R., PHELPS, M.E., and HERSCHMAN, H.R. (1998). Imaging of adenoviral directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J. Nucl. Med. 39, 2003-2011.
19. GAMBHIR, S.S., BAUER, E., BLACK, M.E., LIANG, Q., KOKORIS, M.S., BARRIO, J.R., IYER, M., NAMAVARI, M., PHELPS, M.E., and HERSCHMAN, H.R. (2000). A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc. Natl. Acad. Sci. U.S.A. 97, 2785-2790.
20. GAO, G., ZHOU, X., ALVIRA, M.R., TRAN, P., MARSH, J., LYND, K., XIAO, W., and WILSON, J.M. (2003). High throughput creation of recombinant adenovirus vectors by direct cloning, green-white selection and 1-SceI-mediated rescue of circular adenovirus plasmids in 293 cells. Gene Ther. 10, 1926-1930.
21. GENOVE, G., DEMARCO, U., XU, H., GOINS, W.F., and AHRENS, E.T. (2005). A new transgene reporter for in vivo magnetic resonance imaging. Nat. Med. 11, 450-454.
22. 18F-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET. J. Nucl. Med. 45, 1560-1570.
23. 31P metabolite concentration in human skeletal muscle from RARE image intensity. Magn. Reson. Med. 52, 1036-1042.
24. GREENMAN, R.L., ELLIOTT, M.A., VANDENBORNE, K., SCHNALL, M.D., and LENKINSKI, R.E. (1998). Fast imaging of phosphocreatine using a RARE pulse sequence. Magn. Reson. Med. 39, 851-854.
25. HUSTINX, R., SHIUE, C.Y., ALAVI, A., MCDONALD, D., SHIUE, G.G., ZHUANG, H., LANUTI, M., LAMBRIGHT, E., KARP, J.S., and ECK, S.L. (2001). Imaging in vivo herpes simplex virus thymidine kinase gene transfer to tumour-bearing rodents using positron emission tomography and. Eur. J. Nucl. Med. 28, 5-12.
26. ISHIBASHI, S., BROWN, M.S., GOLDSTEIN, J.L., GERARD, R.D., HAMMER, R.E., and HERZ, J. (1993). Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92, 883-893.
27. JACOBS, A., TJUVAJEV, J.G., DUBROVIN, M., AKHURST, T., BALATONI, J., BEATTIE, B., JOSHI, R., FINN, R., LARSON, S.M., HERRLINGER, U., PECHAN, P.A., CHIOCCA, E.A., BREAKEFIELD, X.O., and BLASBERG, R.G. (2001). Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Res. 61, 2983-2995.
28. JANG, S.K., KRAUSSLICH, H.G., NICKLIN, M.J., DUKE, G.M., PALMENBERG, A.C., and WIMMER, E. (1988). A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62, 2636-2643.
29. KOBAYASHI, K., OKA, K., FORTE, T., ISHIDA, B., TENG, B., ISHIMURA-OKA, K., NAKAMUTA, M., and CHAN, L. (1996). Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. J. Biol. Chem. 271, 6852-6860.
30. KORETSKY, A.P. (1992). Investigation of cell physiology in the animal using transgenic technology. Am. J. Physiol. 262, C261-C275.
31. KORETSKY, A.P., BROSNAN, M.J., CHEN, L.H., CHEN, J.D., and VAN DYKE, T. (1990). NMR detection of creatine kinase expressed in liver of transgenic mice: determination of free ADP levels. Proc. Natl. Acad. Sci. U.S.A. 87, 3112-3116.
32. KOZARSKY, K., GROSSMAN, M., and WILSON, J.M. (1993). Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia. Somatic Cell Mol. Genet. 19, 449-458.
33. KOZARSKY, K.F., MCKINLEY, D.R., AUSTIN, L.L., RAPER, S.E., STRATFORD-PERRICAUDET, L.D., and WILSON, J.M. (1994). In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269, 13695-13702.
34. KOZARSKY, K.F., JOOSS, K., DONAHEE, M., STRAUSS, J.F., III, and WILSON, J.M. (1996). Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene, [erratum appears in Nat. Genet. 1996;13:374]. Nat. Genet. 13, 54-62.
35. LEBHERZ, C., GAO, G., LOUBOUTIN, J.P., MILLAR, J., RADER, D., and WILSON, J.M. (2004). Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia. J. Gene Med. 6, 663-672.
36. LI, L., and LEIGH, J.S. (2004). Quantifying arbitrary magnetic susceptibility distributions with MR. Magn. Reson. Med. 51, 1077-1082.
37. LIANG, Q., SATYAMURTHY, N., BARRIO, J.R., TOYOKUNI, T., PHELPS, M.P., GAMBHIR, S.S., and HERSCHMAN, H.R. (2001). Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther. 8, 1490-1498.
38. LoPRESTI, P., and COHN, M. (1989). Direct determination of creatine kinase equilibrium constants with creatine or cyclocreatine substrate. Biochim. Biophys. Acta 998, 317-320.
39. LOUIE, A.Y., HUBER, M.M., AHRENS, E.T., ROTHBACHER, U., MOATS, R., JACOBS, R.E., FRASER, S.E., and MEADE, T.J. (2000). In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 18, 321-325.
40. PHANEUF, D., MOSCIONI, A.D., LECLAIR, C., RAPER, S.E., and WILSON, J.M. (2004). Generation of a mouse expressing a conditional knockout of the hepatocyte growth factor gene: Demonstration of impaired liver regeneration. DNA Cell Biol. 23, 592-603.
41. RAPER, S.E., GROSSMAN, M., RADER, D.J., THOENE, J.G., CLARK, B.J., III, KOLANSKY, D.M., MULLER, D.W., and WILSON, J.M. (1996). Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. [see comments]. Ann. Surg. 223, 116-126.
42. RAPER, S.E., CHIRMULE, N., LEE, F.S., WIVEL, N.A., BAGG, A., GAO, G.P., WILSON, J.M., and BATSHAW, M.L. (2003). Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80, 148-158.
43. SCATCHARD, G. (1949). The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51, 660-672.
44. SOBAL, G., RESCH, U., and SINZINGER, H. (2004). Modification of low-density lipoprotein by different radioiodination methods. Nucl. Med. Biol. 31, 381-388.
45. STEGMAN, L.D., REHEMTULLA, A., BEATTIE, B., KIEVIT, E., LAWRENCE, T.S., BLASBERG, R.G., TJUVAJEV, J.G., and ROSS, B.D. (1999). Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 96, 9821-9826.
46. TADA, H., MARON, D.J., CHOI, E.A., BARSOUM, J., LEI, H., XIE, Q., LIU, W., ELLIS, L., MOSCIONI, A.D., TAZELAAR, J., FAWELL, S., QIN, X., PROPERT, K.J., DAVIS, A., FRAKER, D.L., WILSON, J.M., and SPITZ, F.R. (2001). Systemic IFN-β gene therapy results in long-term survival in mice with established colorectal liver metastases. J. Clin. Invest. 108, 83-95.
47. TJUVAJEV, J.G., STOCKHAMMER, G., DESAI, R., UEHARA, H., WATANABE, K., GANSBACHER, B., and BLASBERG, R.G. (1995). Imaging the expression of transfected genes in vivo. Cancer Res. 55, 6126-6132.
48. TJUVAJEV, J.G., CHEN, S.H., JOSHI, A., JOSHI, R., GUO, Z.S., BALATONI, J., BALLON, D., KOUTCHER, J., FINN, R., WOO, S.L., and BLASBERG, R.G. (1999). Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res. 59, 5186-5193.
49. TJUVAJEV, J.G., DOUBROVIN, M., AKHURST, T., CAI, S., BALATONI, J., ALAUDDIN, M.M., FINN, R., BORNMANN, W., THALER, H., CONTI, P.S., and BLASBERG, R.G. (2002). Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J. Nucl. Med. 43, 1072-1083.
50. VAN DER EB, M.M., CRAMER, S.J., VERGOUWE, Y., SCHAGEN, F.H., VAN KRIEKEN, J.H., VAN DER EB, A.J., RINKES, I.H., VAN DE VELDE, C.J., and HOEBEN, R.C. (1998). Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration. Gene Ther. 5, 451-458.
51. WALTER, G., BARTON, E.R., and SWEENEY, H.L. (2000). Noninvasive measurement of gene expression in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 97, 5151-5155.
52. WEISSLEDER, R., MOORE, A., MAHMOOD, U., BHORADE, R., BENVENISTE, H., CHIOCCA, E.A., and BASILION, J.P. (2000). In vivo magnetic resonance imaging of transgene expression. Nat. Med. 6, 351-355.